Status:
UNKNOWN
Immune Thrombocytopenia (ITP) Immune-Genetic Assessment
Lead Sponsor:
Azienda Sanitaria-Universitaria Integrata di Udine
Conditions:
Thrombocytopenia
Eligibility:
All Genders
18+ years
Brief Summary
Primary ITP has wide heterogenous biology, presentation and response to therapy. The immune-genetic assessment of ITP may help to identify differences among patients with ITP and optimize the therape...
Eligibility Criteria
Inclusion
- Adult patients with primary ITP
Exclusion
- Secondary ITP
Key Trial Info
Start Date :
September 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
190 Patients enrolled
Trial Details
Trial ID
NCT01196884
Start Date
September 1 2010
Last Update
March 20 2018
Active Locations (13)
Enter a location and click search to find clinical trials sorted by distance.
1
Istituto di Ematologia L. & A. Seragnoli
Bologna, Italy, 40100
2
Department of Hematology and Bone Marrow Transplantation Unit, Oncology Center Armando Businco
Cagliari, Italy, 09100
3
UF Ematologia, Policlinico di Careggi
Florence, Italy
4
U.O. Ematologia 2, IRCCS Cà Granda Ospedale Maggiore Policlinico
Milan, Italy, 20122